1-2 of 2
Aibin Liang
Close
Sort by
Journal Articles

Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma

Clinical Trials & Observations
Zhiyu Liang, Ping Li, Liqing Kang, Lili Zhou, Yang Xu, Shiguang Ye, Juan Du, Bing Li, Yiwen Wang, Lei Yu, Wenbin Qian, Aibin Liang
Journal: Blood Advances
Blood Adv (2022) 6 (1): 293–296.
https://doi.org/10.1182/bloodadvances.2021005814
Published: 2022
Includes: Supplemental data
Journal Articles

Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma

Clinical Trials & Observations
Ying Wang, Chunrui Li, Jieyun Xia, Ping Li, Jiang Cao, Bin Pan, Xu Tan, Hujun Li, Kunming Qi, Xiangmin Wang, Ming Shi, Guangjun Jing, Zhiling Yan, Hai Cheng, Feng Zhu, Haiying Sun, Wei Sang, Depeng Li, Xi Zhang, Zhenyu Li, Junnian Zheng, Aibin Liang, Jianfeng Zhou, Kailin Xu
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5290–5299.
https://doi.org/10.1182/bloodadvances.2021004603
Published: 2021
Includes: Supplemental data